Wednesday, 12 December 2018

Maha govt, Centre to join hands for developing APIs, device parks at MIHAN, Nagpur

21 November 2017 | News

Maharashtra Chief Minister Devendra Fadnavis and Union Minister Nitin Gadkari for developing bulk drugs and medical devices park at Multi-Model International Cargo Hub and Airport at Nagpur (MIHAN) through a collaborative approach.

Maharashtra Chief Minister Devendra Fadnavis and Union Minister for Road Transport, Highways and Shipping Nitin Gadkari are scheduled to discuss an action plan in Mumbai shortly for developing bulk drugs and medical devices park at Multi-Model International Cargo Hub and Airport at Nagpur (MIHAN) through a collaborative approach.

As a part of its policy of ease of doing business, center is planning to develop multi-product Special Economic Zone (SEZ) at MIHAN.Both the ministers are scheduled to discuss modalities and explore areas of investment for setting up common facilities of manufacturing and testing in consultation with pharma industry, according to an official associated with the development.

This comes close on the heels of Maharashtra Food and Drug Administration (FDA) holding talks with pharmaceutical companies in Nashik, Aurangabad, Mumbai, Pune and Thane to explore investment opportunities for developing pharma hub at Multi-Model International Cargo Hub and Airport at Nagpur (MIHAN) multi-product Special Economic Zone.

According to officials, 1000 acres of land in MIHAN SEZ is likely to be developed for API production, which will boost exports and deemed exports. Meanwhile, a technical feasibility study is also underway for setting up of medical device park at MIHAN which will also be equipped with common facilities for testing and manufacturing competencies on par with Andhra Pradesh Med Tech Zone (AMTZ) at Visakhapatnam in Andhra Pradesh.

The MIHAN management is also in the process of earmarking the land, land rate and formulating policies on the same for developing medical device park. Currently, medical device manufacturing by few players have also started at MIHAN.

These ongoing developments which are also in the interest of domestic industry is supplemented by the coming up of institutions like All India Institute of Medical Sciences (AIIMS) in an area of 150 acres in the coming years and Indo UK Medicity in an area of 152 acres at MIHAN. This will pave the way for development of pharma and life sciences cluster in the country.

 The Indo-UK medicity currently being run in coordination with King’s College London for treating foreign patients is aimed at giving boost to medical tourism which will bring in foreign investments. Setting up of a medical device park at MIHAN, Nagpur has been deliberated comprehensively between MIHAN management team and medical device associations.

 Seeing the potential in terms of investment and business prospects, the Maharashtra Airport Development Company Ltd (MADC) is inviting pharmaceutical companies to set up their units in MIHAN project. The project will have a dedicated zone along with certain benefits for the pharmaceutical companies setting up their units in the project.

The multi product Special Economic Zone in MIHAN is sought to be developed for both API and formulations. These units will have the benefits of duty free import or domestic procurement of goods for development, operation and maintenance of SEZ units; 100 per cent income tax exemption on export income for SEZ units for the first 5 years, 50 per cent for the next 5 years thereafter and 50 per cent of the ploughed back export profit for the next 5 years; external commercial borrowing (ECB) by SEZ units up to US$ 500 million in a year without any maturity restriction through recognized banking channels; exemption from central sales tax; exemption from service tax; single window clearance for central and state level approvals; exemption from state sales tax and other levies as extended by the state government and 100 per cent FDI is being allowed.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Does Indian Pharma lack an innovation-friendly ecosystem?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls